Ekaterina Legchenko

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 6

Top Topics

Pulmonary Arterial Hypertension

Top Venues

American journal of respiratory and critical care medicine

Circulation. Heart failure

Science translational medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Ekaterina Legchenko, Philippe Chouvarine, Georg Hansmann
Letter by Legchenko et al Regarding Article, "Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular Failure". Circulation. Heart failure 14 (12) (2021)
Franziska Diekmann, Philippe Chouvarine, Hannes Sallmon, Louisa Meyer-Kobbe, Moritz Kieslich, Brian D Plouffe, Shashi K Murthy, Ralf Lichtinghagen, Ekaterina Legchenko, Georg Hansmann
Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension. International journal of molecular sciences 22 (16) (2021)
David Köhler, Tiago Granja, Julia Volz, Michael Koeppen, Harald F Langer, Georg Hansmann, Ekaterina Legchenko, Tobias Geisler, Tamam Bakchoul, Claudia Eggstein, Helene A Häberle, Bernhard Nieswandt, Peter Rosenberger
Red blood cell-derived semaphorin 7A promotes thrombo-inflammation in myocardial ischemia-reperfusion injury through platelet GPIb. Nature communications 11 (1) (2020)
Harm Jan Bogaard, Ekaterina Legchenko, Ketul R Chaudhary, Xiao-Qing Sun, Duncan J Stewart, Georg Hansmann
Emphysema Is-at the Most-Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension. American journal of respiratory and critical care medicine 200 (11) (2020)
Harm Jan Bogaard, Ekaterina Legchenko, Maximilian Ackermann, Mark P Kühnel, Danny D Jonigk, Ketul R Chaudhary, Xiao-Qing Sun, Duncan J Stewart, Georg Hansmann
The Adult Sprague-Dawley Sugen-Hypoxia Rat Is Still "the One:" A Model of Group 1 Pulmonary Hypertension: Reply to Le Cras and Abman. American journal of respiratory and critical care medicine 201 (5) (2020)
Ekaterina Legchenko, Philippe Chouvarine, Paul Borchert, Angeles Fernandez-Gonzalez, Erin Snay, Martin Meier, Lavinia Maegel, S Alex Mitsialis, Eva A Rog-Zielinska, Stella Kourembanas, Danny Jonigk, Georg Hansmann
PPARγ agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation. Science translational medicine 10 (438) (2019)